Correction to: Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)
- Daniel R. Messroghli1, 2, 3Email author,
- James C. Moon4,
- Vanessa M. Ferreira5,
- Lars Grosse-Wortmann6,
- Taigang He7,
- Peter Kellman8,
- Julia Mascherbauer9,
- Reza Nezafat10,
- Michael Salerno11,
- Erik B. Schelbert12, 13, 14,
- Andrew J. Taylor15,
- Richard B. Thompson16,
- Martin Ugander17,
- Ruud B. van Heeswijk18 and
- Matthias G. Friedrich19, 20, 21, 22
© The Author(s). 2018
Received: 5 November 2017
Accepted: 20 November 2017
Published: 7 February 2018
The original article was published in Journal of Cardiovascular Magnetic Resonance 2017 19:75
Correction to: J Cardiovasc Magn Reson (2017) 19: 75. DOI: 10.1186/s12968-017-0389-8
In the original publication this article was incorrectly published as a “Review article”, this has been corrected to a “Position paper”. Furthermore, in the original publication of this article  the “Competing interests” section was incorrect.
The original publication stated the following competing interests:
The authors declare that they have no competing interests.
The corrected competing interest statement is as followed:
Reza Nezafat has patents pending for methods for scar imaging in patients with arrhythmia, slice interleaved T1 and T2 mapping, and motion correction for parametric mapping, and receives patent royalties from Phillips Healthcare and Samsung Electronics.
Michael Salerno, Peter Kellman, Richard Thompson and Ruud B. van Heeswijk receive research support (source codes) from Siemens Healthineers.
Reza Nezafat receives research support (source codes) from Philips Healthcare.
Erik B. Schelbert has received MRI contrast material donated for research purposes from Bracco Diagnostics and has served on advisory boards for Bayer and Merck.
Martin Ugander states having Institutional research and development agreement regarding cardiovascular magnetic resonance with Siemens.
Matthias G. Friedrich is board member and consultant of Circle Cardiovascular Imaging Inc.
Vanessa M. Ferreira receives support by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC) and British Heart Foundation Centre of Research Excellence, Oxford.
Authors Daniel Messroghli, Lars Grosse-Wortmann, Taigang He, Julia Mascherbauer, James C. Moon and Andrew J. Taylor report no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Messroghli DR, Moon JC, Ferreira VM, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson. 2017;19:75. https://doi.org/10.1186/s12968-017-0389-8 View ArticlePubMedPubMed CentralGoogle Scholar